Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001127602-19-034976
Filing Date
2019-12-16
Accepted
2019-12-16 11:17:18
Documents
1
Period of Report
2019-05-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4a.html 4/A  
1 PRIMARY DOCUMENT form4a.xml 4/A 4589
  Complete submission text file 0001127602-19-034976.txt   6102
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Issuer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address
Fleming Michael (Reporting) CIK: 0001772183 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-06571 | Film No.: 191286315